CDKN1B and cholangiocarcinoma: The gain-of-function of HOXA5 in CC cell lines confirmed that HOXA5 could act as a tumor suppressor by inducing the expression of cell cycle inhibitor p27 and suppressing the phosphorylation of AKT (Wang et al. 2019c).